Identifying individuals at risk of needing CKD associated medications in a European kidney disease cohort

Identifying individuals at risk of needing CKD associated medications in a European kidney disease cohort

Abstract Background The consequences of chronic kidney disease (CKD) can be addressed with a range of pharmacotherapies primarily prescribed by nephrologists. More accurate information regarding future CKD-related pharmacotherapy requirements could guide clinical decisions including follow-up freque...

Full description

Bibliographic Details
Main Authors: Eleni Stamellou, Turgay Saritas, Marc Froissart, Florian Kronenberg, Peter Stenvinkel, David C. Wheeler, Kai-Uwe Eckardt, Jürgen Floege, James Fotheringham
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Nephrology
Subjects:
CKD G4/G5
CKD-MBD
Renal anemia
ESAs
VDRA
Phosphate binders
Online Access:https://doi.org/10.1186/s12882-024-03497-y

Internet

https://doi.org/10.1186/s12882-024-03497-y

Similar Items